IL6 and neoplasm: Mechanistically, LPC downregulates the Gal-3/Gal-3BP/IL6 axis between NB cells and iBMSC in an NQO1-dependent manner, thereby inhibiting the tumor-promoting effect of iBMSC-derived IL6 on NB cells.